The study of p53 and CA19-9 prognostic molecular markers in colorectal carcinomas.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 20809023
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical significance of pT sub-classification in surgical pathology of colorectal cancer

  2010cited by this paper
• International Trends in Colorectal Cancer Incidence Rates

  2009cited by this paper
• Increase in Incidence of Colorectal Cancer Among Young Men and Women in the United States

  2009cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Prognostic significance of depth of invasion, vascular invasion and numbers of lymph node retrievals in combination for patients with stage II colorectal cancer undergoing radical resection

  2008cited by this paper
• Surgical Resection of Stage IV Colorectal Cancer and Prognosis

  2008cited by this paper
• Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach.

  2007cited by this paper
• Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastases.

  2007cited by this paper
• Type 2 diabetes mellitus and CA 19-9 levels.

  2007cited by this paper
• Comparative Analysis of Predictive Biomarkers for Therapeutical Strategies in Colorectal Cancer

  2007cited by this paper
• [Study on the prognostic factors of colorectal cancer and on suggested model for prediction].

  2007cited by this paper
• Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline.

  2007cited by this paper
• ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.

  2006cited by this paper
• Jass Carcinoma of the colon and rectum Adenocarcinoma

  2006cited by this paper
• Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto sigmoid cancer.

  2005cited by this paper
• Changing trends in the incidence, stage, survival, and screen-detection of colorectal cancer: a population-based study.

  2005cited by this paper
• Intratumoral molecular or genetic markers as predictors of clinical outcome with chemotherapy in colorectal cancer.

  2005cited by this paper
• Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline.

  2005cited by this paper
• P53 abnormalities and outcomes in colorectal cancer: a systematic review

  2005cited by this paper
• Assessment of staging, prognosis and mortality of colorectal cancer by tumor markers: receptor erbB-2 and cadherins.

  2005cited by this paper
• Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1995 to 1999.

  2004cited by this paper
• Prognostic significance of mucinous component in colorectal carcinoma

  2004cited by this paper
• Does Serum CA19-9 Play a Practical Role in the Management of Patients With Colorectal Cancer?

  2004cited by this paper
• Genetic alterations in locally advanced stage II/III colon cancer: a search for prognostic markers.

  2004cited by this paper
• Systematic review of genetic influences on the prognosis of colorectal cancer

  2004cited by this paper
• Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma.

  2003cited by this paper
• Survival After Curative Resection for Mucinous Adenocarcinoma of the Colorectum

  2003cited by this paper
• Molecular predictors of prognosis and response to therapy in colorectal cancer.

  2003cited by this paper
• Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients.

  2003cited by this paper
• Is There a True “shift” to the Right Colon in the Incidence of Colorectal Cancer?

  2003cited by this paper
• CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.

  2002cited by this paper
• Clinical significance of prognostic and predictive markers in colorectal cancer

  2002cited by this paper
• CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.

  2002cited by this paper
• Serum p53 antibody as a useful marker for monitoring of treatment of superficial colorectal adenocarcinoma after endoscopic resection

  2001cited by this paper
• Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.

  2000cited by this paper
• Colorectal cancer: molecules and populations.

  1999cited by this paper
• CEA and CA 19-9 as prognostic indexes in colorectal cancer.

  1999cited by this paper
• Survival of patients with colorectal carcinoma

  1999cited by this paper
• Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer.

  1999cited by this paper
• CA19‐9 as a predictor of recurrence in patients with colorectal cancer

  1997cited by this paper
• Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer

  1995cited by this paper
• The prognostic value of CEA, beta HCG, AFP, CA125, CA19-9 and C-erb B-2, beta HCG immunohistochemistry in advanced colorectal cancer.

  1995cited by this paper
• Immunohistochemical expression of carbohydrate antigen 19-9 in colorectal carcinoma.

  1994cited by this paper
• Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma.

  1994cited by this paper
• Asians and Pacific Islanders in the United States

  1993cited by this paper
• Failure of CA19-9 to detect asymptomatic colorectal carcinoma.

  1991cited by this paper
• Immunohistochemical comparison of Lea, monosialosyl Lea (CA 19-9), and disialosyl Lea antigens in human colorectal and pancreatic tissues.

  1988cited by this paper
• Follow-up of colorectal cancer resected for cure

  1987cited by this paper
• Immunohistochemical Cal9-9 in primary colonic polyps and polyps synchronous with colorectal cancer.

  1987cited by this paper
• Distribution of GICA in normal gastrointestinal and endocervical mucosae and in mucinous ovarian cysts using antibody NS 19-9.

  1986cited by this paper
• Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry.

  1986cited by this paper
• Gastrointestinal carcinoma‐associated antigen detected by a monoclonal antibody in dysplasia and adenocarcinoma associated with chronic ulcerative colitis

  1985cited by this paper
• Expression of carbohydrate antigen 19-9 and stage-specific embryonic antigen 1 in nontumorous and tumorous epithelia of the human colon and rectum.

  1985cited by this paper
• Distribution of Monoclonal Antibody-Defined Monosialoganglioside in Normal and Cancerous Human Tissues: An Immunoperoxidase Study

  1983cited by this paper
• Gastrointestinal cancer-associated antigen in immunoperoxidase assay.

  1982cited by this paper

• Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data

  2018cites this paper
• Toxicidad por radioterapia en zona pélvica en el tratamiento del cáncer colorrectal

  2017cites this paper
• CD10 and CA19.9 immunohistochemical expression in transitional cell carcinoma of the urinary bladder

  2013cites this paper
• A step towards refining prognostication in individual patients with bladder cancer

  2013cites this paper
• [Tumor markers in colorectal cancer].

  2013cites this paper
• Marcadores tumorales en el cáncer colorrectal

  2013cites this paper